Given misregulation of the TGF-β pathway that occurs with age and in Alzheimer’s Disease (AD) patients31–33, we first examine whether Acvr1c declines with age in mouse and human hippocampus. Here, ACVR1C is linked to early-onset autosomal dominant Alzheimer disease.